Management of febrile neutropenia: ESMO Clinical Practice Guidelines

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

Life Sciences, Microbiology, Pharmacology +10

The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

Jean Klášterský, Marianne Paesmans, Edward Rubenstein et al. · Journal of Clinical Oncology · 2000 · 1.2K citations

Medicine, Health Sciences, Oncology +15

Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Hedy Teppler, Gerald R. Donowitz et al. · New England Journal of Medicine · 2004 · 921 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

Oliver A. Cornely, Johan Maertens, Mark Bresnik et al. · Clinical Infectious Diseases · 2007 · 744 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

Michael Cullen, Neil Steven, Lucinda Billingham et al. · New England Journal of Medicine · 2005 · 423 citations · Full text

Medicine, Oncology, Pharmacology +17